Proteomic Analysis of Low-Grade Serous Ovarian Cancer and Comparing It with Non-cancerous Ovarian

被引:1
|
作者
Bashizadeh Fakhar H. [1 ]
Rezaie-Tavirani M. [1 ]
Zali H. [2 ]
Darkhaneh R.F. [3 ]
Nejad E.K. [4 ]
Aghazadeh M.H. [5 ]
机构
[1] Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran
[2] Proteomics Research Center, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran
[3] Department of Obstetrics and Gynecology, Reproductive Health Research Center, Guilan University of Medical Sciences, Rasht, Guilan
[4] Department of Biostatistics, Guilan Road Truma Research Center, Guilan University of Medical Sciences, Rasht
[5] Azad Medical University, Tehran
关键词
Comparison; Low-grade serous ovarian cancer; Non-cancerous ovarian; Proteomics;
D O I
10.1007/s40944-018-0187-8
中图分类号
学科分类号
摘要
Background: In Iran, ovarian cancer is the eighth most common cancer. Serous is considered as the most common of all ovarian cancers. It is usually deadly due to late diagnosis. Moreover, as all studies so far have considered metastatic or high-stage ovarian cancer, this study sought low-grade ovarian serous in human, which is of high importance and aimed at obtaining protein biomarkers that may be useful in diagnosis and treatment of ovarian serous cancer. Materials and Methods: In this experimental study, ten patients with proved low-grade serous ovarian cancer and ten women without ovarian cancer, healthy, and cancerous tissue samples were obtained to perform proteomics. All tissue proteins were purified using standard separation methods, and proteins were separated using two-dimensional electrophoresis. Healthy and tumorous tissue proteomes were compared, and the extent of protein expression was analyzed. Results: This study identified 212 proteins, 41 of which had changes in protein expression in cancer state. The expression of eight proteins was suppressed, and five proteins were expressed in cancerous group. Thirteen proteins in cancer sample showed increase in expression and 15 proteins reduced expression in cancerous tissue. Conclusion: It seems that in this disease, the expression of a large number of proteins in cancerous tissues changed, most of them decreased or not expressed at all. These changed proteins can be effective as biomarker in diagnosis and treatment of this disease. © 2018, Association of Gynecologic Oncologists of India.
引用
下载
收藏
相关论文
共 50 条
  • [1] Low-grade serous ovarian cancer: A review
    Kaldawy, Anis
    Segev, Yakir
    Lavie, Ofer
    Auslender, Ron
    Sopik, Victoria
    Narod, Steven A.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (02) : 433 - 438
  • [2] Epidemiology of low-grade serous ovarian cancer
    Plaxe, Steven C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 198 (04) : 459.e1 - 459.e9
  • [3] Low-grade serous ovarian cancer in pregnancy
    Peters, Inge
    Testa, Antonia Carla
    Arciuolo, Damiano
    Amant, Frederic
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (06) : 804 - 808
  • [4] Low-grade serous ovarian cancer: State of the science
    Slomovitz, Brian
    Gourley, Charlie
    Carey, Mark S.
    Malpica, Anais
    Shih, Ie-Ming
    Huntsman, David
    Fader, Amanda N.
    Grisham, Rachel N.
    Schlumbrecht, Matthew
    Sun, Charlotte C.
    Ludemann, Jane
    Cooney, Gail Austin
    Coleman, Robert
    Sood, Anil K.
    Mandi, Haider
    Wong, Kwong K.
    Covens, Allan
    O'Malley, David M.
    Lecuru, Fabrice
    Cobb, Lauren P.
    Caputo, Thomas A.
    May, Taymaa
    Huang, Marilyn
    Siemon, John
    Fernandez, Marta Llaurado
    Ray-Coquard, Isabelle
    Gershenson, David M.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 715 - 725
  • [5] Low-Grade Serous Ovarian Cancer: a Unique Disease
    Schmeler, Kathleen M.
    Gershenson, David M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (06) : 519 - 523
  • [6] Novel therapeutics in low-grade serous ovarian cancer
    Cobb, Lauren
    Gershenson, David
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (03) : 377 - 384
  • [8] Low-grade serous ovarian cancer: a unique disease
    Kathleen M. Schmeler
    David M. Gershenson
    Current Oncology Reports, 2008, 10 : 519 - 523
  • [9] Low-grade Serous Ovarian Carcinoma
    Ricciardi, Enzo
    Baert, Thais
    Ataseven, Beyhan
    Heitz, Florian
    Prader, Sonia
    Bommert, Mareike
    Schneider, Stephanie
    du Bois, Andreas
    Harter, Philipp
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2018, 78 (10) : 972 - 976
  • [10] Redefining the Standard of Care for Low-Grade Serous Ovarian Cancer
    Manning-Geist, Beryl L.
    Cantor, Tal
    O'Cearbhaill, Roisin E.
    Grisham, Rachel N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (05)